Statistics

Total Visits

Views
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice66

Select a period of time:

Number of views in the range

Views
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice40

Views

Views
December 20251
January 20260
February 20261
March 202615
April 20262
May 20265
June 202616
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States21
Netherlands6
United Kingdom3
Kenya2
Argentina2
Chile1
Colombia1
Costa Rica1
Ecuador1
Finland1
 

Top cities views

Views
San Jose10
Groningen6
Andalucía1
Greenville1
Greenwich1
Helsinki1
Jeffersonville1
Junín1
Kearny1
Las Vegas1